These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17535281)

  • 1. Local expression of TAP-1 and MHC-I molecules and their relationship in condyloma acuminatum.
    Tao J; Zhang XP; Chen XP; Li Y; Liu YQ; Tian J; Huang CZ; Shen GX; Tu YT
    Clin Exp Dermatol; 2007 Sep; 32(5):550-5. PubMed ID: 17535281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease.
    Vambutas A; Bonagura VR; Steinberg BM
    Clin Diagn Lab Immunol; 2000 Jan; 7(1):79-85. PubMed ID: 10618282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of HLA class I antigen in human papillomavirus type 16 E7 expressing HaCaT cells: correlate with TAP-1 expression.
    Li W; Deng XM; Wang CX; Zhang X; Zheng GX; Zhang J; Feng JB
    Int J Gynecol Cancer; 2010 Feb; 20(2):227-32. PubMed ID: 20134267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of the peptide transporters in escape variants of human renal cell carcinomas.
    Seliger B; Höhne A; Jung D; Kallfelz M; Knuth A; Jaeger E; Bernhard H; Momburg F; Tampé R; Huber C
    Exp Hematol; 1997 Jul; 25(7):608-14. PubMed ID: 9216736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of expression of MHC class I molecules and TAP genes in malignant human cell lines.
    Kaczmarek M; Frydrychowicz M; Rubis B; Mizera-Nyczak E; Nieruchalska E; Sikora J; Kaczmarek E
    Folia Histochem Cytobiol; 2007; 45(3):205-14. PubMed ID: 17951169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.
    Seliger B; Hohne A; Knuth A; Bernhard H; Meyer T; Tampe R; Momburg F; Huber C
    Cancer Res; 1996 Apr; 56(8):1756-60. PubMed ID: 8620489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport.
    Vambutas A; DeVoti J; Pinn W; Steinberg BM; Bonagura VR
    Clin Immunol; 2001 Oct; 101(1):94-9. PubMed ID: 11580231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.
    Wang F; Li X; Annis B; Faustman DL
    Hum Gene Ther; 1995 Aug; 6(8):1005-17. PubMed ID: 7578413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
    Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
    Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide loading of nascent MHC class I molecules.
    Vukmanović S; Lilić M; Santori FR; Demaria S; Kulig K
    Arch Immunol Ther Exp (Warsz); 2001; 49(3):195-201. PubMed ID: 11478393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transporter associated with antigen processing: a key player in adaptive immunity.
    Eggensperger S; Tampé R
    Biol Chem; 2015 Sep; 396(9-10):1059-72. PubMed ID: 25781678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are transporter associated with antigen processing (TAP) and tapasin class I MHC chaperones?
    Solheim JC; Carreno BM; Hansen TH
    J Immunol; 1997 Jan; 158(2):541-3. PubMed ID: 8992965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression may be present within condyloma acuminata.
    Le Poole C; Denman CJ; Arbiser JL
    J Am Acad Dermatol; 2008 Dec; 59(6):967-74. PubMed ID: 19022100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
    Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
    Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of MHC class I antigen in human cancer cell lines with defective LMP-7.
    Yoon SJ; Kang JO; Park JS; Kim NK; Heo DS
    Anticancer Res; 2000; 20(2A):949-53. PubMed ID: 10810379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of local cellular immunity in interferon-responsive and -nonresponsive human papillomavirus-associated lesions.
    Arany I; Tyring SK
    Sex Transm Dis; 1996; 23(6):475-80. PubMed ID: 8946632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gamma.
    Juffs H; Fowler N; Saal R; Grimmett K; Beasley S; O'Sullivan B; Frazer I; Gill D; Thomas R
    Pathology; 2004 Feb; 36(1):69-76. PubMed ID: 14757560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in laryngeal squamous cell carcinoma].
    Zeng Q; Wang XL; Xu ZG; Lü N; Zheng S; Zhao QZ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):234-40. PubMed ID: 22805026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mechanisms underlying transporter associated with antigen processing deficiency in metastatic murine carcinomas.
    Setiadi AF; David MD; Chen SS; Hiscott J; Jefferies WA
    Cancer Res; 2005 Aug; 65(16):7485-92. PubMed ID: 16103103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.